rs1025977498
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6BS2_Supporting
The NM_000517.6(HBA2):c.95+39C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00044 ( 0 hom., cov: 4)
Exomes 𝑓: 0.000071 ( 2 hom. )
Failed GnomAD Quality Control
Consequence
HBA2
NM_000517.6 intron
NM_000517.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.520
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-173046-C-G is Benign according to our data. Variant chr16-173046-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 619683.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR,Digenic geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBA2 | ENST00000251595.11 | c.95+39C>G | intron_variant | Intron 1 of 2 | 1 | NM_000517.6 | ENSP00000251595.6 | |||
HBA2 | ENST00000484216.1 | c.62+39C>G | intron_variant | Intron 1 of 1 | 1 | ENSP00000495899.1 | ||||
HBA2 | ENST00000482565.1 | n.153C>G | non_coding_transcript_exon_variant | Exon 1 of 2 | 1 | |||||
HBA2 | ENST00000397806.1 | c.-1-79C>G | intron_variant | Intron 1 of 2 | 2 | ENSP00000380908.1 |
Frequencies
GnomAD3 genomes AF: 0.000488 AC: 11AN: 22536Hom.: 0 Cov.: 4 show subpopulations
GnomAD3 genomes
AF:
AC:
11
AN:
22536
Hom.:
Cov.:
4
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000257 AC: 16AN: 62336 AF XY: 0.000252 show subpopulations
GnomAD2 exomes
AF:
AC:
16
AN:
62336
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000708 AC: 33AN: 465818Hom.: 2 Cov.: 3 AF XY: 0.0000610 AC XY: 15AN XY: 246012 show subpopulations
GnomAD4 exome
AF:
AC:
33
AN:
465818
Hom.:
Cov.:
3
AF XY:
AC XY:
15
AN XY:
246012
Gnomad4 AFR exome
AF:
AC:
18
AN:
11902
Gnomad4 AMR exome
AF:
AC:
12
AN:
25396
Gnomad4 ASJ exome
AF:
AC:
0
AN:
14976
Gnomad4 EAS exome
AF:
AC:
0
AN:
31070
Gnomad4 SAS exome
AF:
AC:
0
AN:
48736
Gnomad4 FIN exome
AF:
AC:
0
AN:
29596
Gnomad4 NFE exome
AF:
AC:
0
AN:
275828
Gnomad4 Remaining exome
AF:
AC:
3
AN:
26322
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000444 AC: 10AN: 22510Hom.: 0 Cov.: 4 AF XY: 0.000305 AC XY: 3AN XY: 9826 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
10
AN:
22510
Hom.:
Cov.:
4
AF XY:
AC XY:
3
AN XY:
9826
Gnomad4 AFR
AF:
AC:
0.00154799
AN:
0.00154799
Gnomad4 AMR
AF:
AC:
0.0014881
AN:
0.0014881
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0
AN:
0
Gnomad4 OTH
AF:
AC:
0.00271739
AN:
0.00271739
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Feb 03, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 26, 2017
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at